MOXO Analytics is officially announced as an innovative online, science-based and clinically validated system for ADHD analysis.
– Minimizing the cost and inconvenience of diagnosing Attention Deficit Hyperactivity Disorder (ADHD) an innovative platform from Neurotech Solutions, Inc. is announced to help professionals make a difference in the field. Having launched their MOXO Analytics platform Neurotech sets about to support professionals as they work to help the 7.5 percent of school-age children affected by the disorder. Offering an inventive answer for the many children and adults who still remain undiagnosed MOXO Analytics offers comprehensive resources and two ADHD online assessment tests.
The MOXO Analytics ADHD online test offers two versions – the 14-minute children’s test for ages 7 to 12 and the 18-minute adult’s test for ages 13 and above. With the use of a computerized d-CPT, that serves as an objective tool to evaluate a patient’s attentiveness, the Neurotech MOXO Analytics platform uses distracter systems to simulate the daily environment of participants. It then uses a distinctive clinical system to deliver comprehensive and measurable indices regarding developmental, cognitive and behavioral components. From there its objectively generated data optimizes the process of diagnosing and treating the disorder while reducing expenses. Simply stated, it produces results within weeks instead of months.
The culmination of years of research the platform is recognized as an “objective decision-support tool” and is the only clinical system of its kind. Giving numeric data to compare the scores of patients both before and after treatment MOXO takes diagnosis all the way through to therapy. Adva Peled Levie, VP of Marketing and Sales at Neurotech Solutions, Ltd. said of MOXO Analytics, “We’ve worked hard to create an online testing tool that’s both convenient and comprehensive for helping clinicians diagnose and treat ADHD. Our interface is user-friendly and approachable and we’re very careful to maximize the privacy of our participants by using HIPAA standards.”
About Neurotech Solutions, Ltd.:
Neurotech Solutions Ltd. is a startup company that develops cutting-edge
Internet-based software technologies. The company’s efforts are focused on research, evaluation, and improvement of human cognition and behavior with a special emphasis on Attention-Deficit/Hyperactivity Disorder (ADHD).
For more information visit www.moxo-adhdtest.com.